Study finds that many women with early breast cancer can safely skip chemo
A new study has found that most women who have early-stage breast cancer might not need to go through chemotherapy, with surgery and hormone therapy being enough.
The study was presented Sunday at the American Society of Clinical Oncology meeting and published in the New England Journal of Medicine. Researchers focused on women with early-stage breast cancer that had not spread and was hormone-positive. For these patients, they typically undergo surgery and then take hormone-blocking drugs, but they are often urged to also go through chemotherapy to kill any cancer cells that remain.
During the study, the largest one ever done on breast cancer, 10,273 patients took a test called Oncotype DX, which uses a biopsy sample to see how cells are growing and how they respond to hormone therapy, in order to estimate the risk the cancer will recur, The Associated Press reports. The 17 percent of women who had high-risk scores were advised to undergo chemotherapy, while the 16 percent of patients with a low-risk score were told they could skip it. The 67 percent of women at intermediate risk were split into two groups, with all of them having surgery and hormone therapy, but one group also going through chemo.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
After nine years, 94 percent of both groups are still alive, and 84 percent are alive without any signs of cancer, showing the chemo didn't change anything. "The impact is tremendous," Dr. Joseph Sparano of Montefiore Medical Center in New York, the study's leader, told AP. The researchers say that the findings do not apply to women who have larger tumors or whose cancer has spread, and they need to conduct studies on those patients.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia is night editor for TheWeek.com. Her writing and reporting has appeared in Entertainment Weekly and EW.com, The New York Times, The Book of Jezebel, and other publications. A Southern California native, Catherine is a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Puffed rice and yoga: inside the collapsed tunnel where Indian workers await rescue
Speed Read Workers trapped in collapsed tunnel are suffering from dysentery and anxiety over their rescue
By Sorcha Bradley, The Week UK Published
-
More than 2,000 dead following massive earthquake in Morocco
Speed Read
By Justin Klawans Published
-
Mexico's next president will almost certainly be its 1st female president
Speed Read
By Peter Weber Published
-
North Korea's Kim to visit Putin in eastern Russia to discuss arms sales for Ukraine war, U.S. says
Speed Read
By Peter Weber Published
-
Gabon's military leader sworn in following coup in latest African uprising
Speed Read
By Justin Klawans Published
-
Nobody seems surprised Wagner's Prigozhin died under suspicious circumstances
Speed Read
By Peter Weber Published
-
Western mountain climbers allegedly left Pakistani porter to die on K2
Speed Read
By Justin Klawans Published
-
'Circular saw blades' divide controversial Rio Grande buoys installed by Texas governor
Speed Read
By Peter Weber Published